MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
This marks Glenmark's first synthetic decapeptide injectable approval
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
Subscribe To Our Newsletter & Stay Updated
